Certified by Founder Lodge
Tubulis GmbH
Germany - Munich, Bayern
START UP
1 Disclosed Funding Rounds $359,197,300
0 Participating Investments
-
Founded date
2012
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antib
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 16 ,2025 | Series C | $359,197,300 |
Seventure Partners
Wellington Management
Andera Partners
EQT Life Sciences
Nextech Invest
OCCIDENT
Bayern Kapital GmbH
Ascenta Capital
Frazier Life Sciences
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Valinor | $13,000,000 | (Dec 12, 2025)
Double (1) | $6,500,000 | (Dec 12, 2025)
Keeper | $4,000,000 | (Dec 12, 2025)
OnCorps AI | $55,000,000 | (Dec 12, 2025)
Cyphlens | $3,800,000 | (Dec 12, 2025)
